Deutsche Bank Ag\ Beam Therapeutics Inc. Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Deutsche Bank Ag\ holds 43,637 shares of BEAM stock, worth $1.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,637

Previous 861,993 94.94%

Holding current value

$1.1 Million

Previous $20.2 Million 94.71%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$22.57 - $33.14 $18.5 Million - $27.1 Million	-818,356 Reduced 94.94%	43,637 $1.07 Million
Q2 2024 Aug 14, 2024	BUY	$21.22 - $32.66 $17 Million - $26.2 Million	801,238 Added 1318.8%	861,993 $20.2 Million
Q1 2024 May 15, 2024	BUY	$23.46 - $45.07 $89,148 - $171,266	3,800 Added 6.67%	60,755 $2.01 Million
Q4 2023 Feb 14, 2024	BUY	$17.69 - $30.76 $2,759 - $4,798	156 Added 0.27%	56,955 $1.55 Million
Q3 2023 Nov 09, 2023	BUY	$23.01 - $32.46 $100,806 - $142,207	4,381 Added 8.36%	56,799 $1.37 Million
Q2 2023 Aug 14, 2023	SELL	$29.32 - $35.99 $399,103 - $489,895	-13,612 Reduced 20.61%	52,418 $1.67 Million
Q1 2023 May 15, 2023	BUY	$30.15 - $48.79 $410,914 - $664,958	13,629 Added 26.01%	66,030 $2.02 Million
Q4 2022 Feb 13, 2023	BUY	$36.73 - $51.6 $75,149 - $105,573	2,046 Added 4.06%	52,401 $2.05 Million
Q3 2022 Nov 14, 2022	BUY	$39.79 - $70.31 $53,119 - $93,863	1,335 Added 2.72%	50,355 $2.4 Million
Q2 2022 Aug 11, 2022	BUY	$29.86 - $62.36 $113,945 - $237,965	3,816 Added 8.44%	49,020 $1.9 Million
Q1 2022 May 13, 2022	SELL	$53.73 - $82.16 $159,363 - $243,686	-2,966 Reduced 6.16%	45,204 $2.59 Million
Q4 2021 Feb 11, 2022	BUY	$68.02 - $99.06 $28,976 - $42,199	426 Added 0.89%	48,170 $3.84 Million
Q3 2021 Nov 04, 2021	BUY	$84.37 - $133.6 $1.4 Million - $2.22 Million	16,650 Added 53.55%	47,744 $4.15 Million
Q2 2021 Aug 11, 2021	SELL	$64.12 - $128.71 $1.7 Million - $3.41 Million	-26,473 Reduced 45.99%	31,094 $4 Million
Q1 2021 May 13, 2021	BUY	$71.28 - $120.75 $1.91 Million - $3.23 Million	26,762 Added 86.88%	57,567 $4.61 Million
Q4 2020 Feb 16, 2021	BUY	$22.24 - $95.63 $257,339 - $1.11 Million	11,571 Added 60.16%	30,805 $2.51 Million
Q3 2020 Nov 12, 2020	BUY	$19.0 - $30.57 $248,102 - $399,183	13,058 Added 211.43%	19,234 $473,000
Q2 2020 Aug 13, 2020	BUY	$15.26 - $28.66 $27,101 - $50,900	1,776 Added 40.36%	6,176 $173,000
Q1 2020 May 14, 2020	BUY	$13.31 - $29.2 $58,564 - $128,480	4,400 New	4,400 $79,000

Others Institutions Holding BEAM

# of Institutions

236

Shares Held

75.2M

Call Options Held

438K

Put Options Held

232K

View Full List

About Beam Therapeutics Inc.

Ticker BEAM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,354,600
Market Cap $1.78B
Description
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...

More about BEAM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account